Skip to navigation Skip to content

Gastric cancer (GC) Programs in Pharmaceutical Benefits Scheme (PBS) 012-18051116

This document outlines details of PBS-subsidised trastuzumab for patients with gastric cancer (GC).

For information on how to process a PBS Authority, see Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System). Contact a Local Peer Support (LPS) if unsure on how to action an application.

Gastric Cancer (GC) quick reference

Restrictions

Authority level and section

PA assessment

Processing system

Prescriber type

Prescriber self-serve

Initial

Streamlined

S100:

trastuzumab

(Telephone for increased quantities for patients >125kg)

No

OPA

Not specified

N/A

Continuing

Streamlined

S100:

trastuzumab

(Telephone for increased quantities for patients >125kg)

No

OPA

Not specified

N/A